-
Eli Crane Defeats Jonathan Nez in Tight Arizona Congressional Race
-
David Walliams Identified as Celebrity in Sexual Misconduct Allegations After Legal Bid
-
Sherilyn Smith Encourages Women to Embrace Scars as Symbols of Resilience
-
Korea's Severe Asthma Patients Blocked from Biologics by Restrictive Reimbursement Rules
-
Belgium Signs Contract for 20 Rheinmetall Skyranger Air Defence Systems
-
Shanghai Science and Technology Museum Signs Pacts With London and Ottawa Institutions at CIIE
-
BioTech Breakthrough Acknowledges Champions Oncology Innovation with the "Contract Research and Development Innovation Award"
-
New Gold IRA Investing Guide Explains How to Buy Gold in an IRA for American Consumers
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 10
-
Fulcrum Metals PLC Announces Fulcrum to Increase Shareholding in Loyalist
-
Spectrocell Strengthens Product Discovery and Customer Engagement with Bioz Badges
-
3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
-
Apex Extends Trinity Zone in West Step-out Drilling With 2.52% REO Over 223.3 m and 2.49% REO Over 123.3 m at Rift
-
KIFFIK Biomedical Recognized as Top Biomarker Access Technology 2026 by Life Sciences Review
-
Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results
-
Precigen Posts Strong Q3: PAPZIMEOS Net Revenue Rose 37%; Positive Cash Flow Achieved Ahead of Schedule
-
Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
-
Gamma Resources Announces Planned Radon Flux Baseline Survey at Mesa Arc Uranium Project in New Mexico, Provides Update on Project Timelines
-
China Explores a New Pathway for Medical AI: Bridging R&D Innovation and Clinical Adoption
-
Critical Elements' 10,000-Meter Summer Drill Program at Rose West Continues to Deliver Positive Results
-
Aztec Drills 70.1 Meters of 0.80 g/t AuEq (0.49 g/t Au and 16.85 g/t Ag) from Surface in TR26-54 at the Tombstone Project, Arizona
-
Silicon Publishing Launches Prism, Bringing AI-Assisted Automation to Database Publishing
-
Zeb Nickel Commences Diamond Drilling at the Zeb Nickel Project
-
Aston Bay Announces Pre-Feasibility Study Results and Maiden Mineral Reserve for the Storm Copper Project, Nunavut
-
Electrovaya to Participate in Upcoming Investor Conferences
-
Moderna to Present at Upcoming Conference in November 2026
-
INEO Invited to 15th Annual ROTH Technology Conference in New York
-
Odyssey Behavioral Healthcare Launches Virtual Intensive Outpatient Mental Health Treatment for Adults
-
Nextech3D.ai to Report Fiscal Second Quarter 2027 Financial Results and Host Investor Webinar on November 19, 2026 at 4:30 PM ET
-
Adcore Reports Third Quarter 2026 Results: Gross Margin Rises to 64%, Operating Loss Halved, Cash Up to $4.3 Million as Restructuring Takes Hold
-
Sterling Metals Announces Fully Allocated Private Placement of Units, Flow-Through Shares and Charity Flow-Through Units
-
Wash100 Award, GovCon Industry's Highest Honor, Opens Nominations for 2027 Season
-
Greene Concepts Highlights Groundwater Resources and Commercial Opportunities
-
SNZweig Forms AEC Industry Advisory Council
-
Allstar Health Brands Confirms MLS NEXT Expansion Bid to Anchor a Permanent Training Structure and a Professional Pathway
-
Securitas Healthcare Introduces a New Era of RTLS Built for the Future of Healthcare Operations
-
Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
-
Cardiff Lexington To Report Third Quarter 2026 Financial Results and Host Conference Call on Monday, November 16, 2026
-
ATWEC Technologies, Inc. (OTCID:ATWT) Reports Third Quarter 2026 Revenue of $12.46 Million, Up 37% Year-over-Year
-
ByNext Joins the Bilt Neighborhood: Reaching More Customers by Integrating Its Technology with Bilt Neighborhood OS
-
Your Patients Are Asking AI About You. AimwellBio Lets Every Physician See the Answer, Free.
-
Peraso to Showcase DUNE 60 GHz Wireless Platform at Africa Tech Festival 2026
-
Four Nines Gold Intersects 67 Metres at 1.78 g/t Gold, Reinforing Emerging Gold Corridor at Hayden Hill
-
Medical Care Technologies Inc. (OTCID:MDCE) Subsidiaries to Manage $20 Million in Private Collectibles Assets
-
Opportunistic Trader ETF(WZRD) to Delist and Liquidate
-
LiveOne (Nasdaq: LVO) Releases Preliminary H1 Fiscal 2027 Results: $37.3 Million in Revenue and Record Audio Adjusted EBITDA* of $7.8 Million, Up 619% Year-Over-Year
-
Critics and Listeners Agree: Eylsia Nicolas' "The Wedding Song" Nominated for GlacerFM's Best Pop Song 2026; Second Consecutive Listener's Choice Nomination Follows Widespread Critical Recognition and Growing Global Audience
-
GoodData.AI Launches the Agentic Serving Plane, a New Category of Enterprise Data Infrastructure for AI Agents
-
Guard Home Warranty Launches Claims 2.0: A Real US-Based Person in 16 Seconds, Claims Reimbursed Instantly
-
Envision Pharma Group appoints Leigh Anne Siino as Senior Vice President of Commercial, Two Labs and Riparian
The Hidden Cause of Back Pain No One Talks About - and the Surgeon Who's Changing Everything
LOS ANGELES, CA / ACCESS Newswire / April 29, 2025 / In the world of spine surgery, few conditions remain as misunderstood and underdiagnosed as Bertolotti Syndrome - a complex, often-overlooked cause of chronic lower back pain. Dr. Hooman Melamed, a world-renowned Orthopedic Spine Surgeon based in Beverly Hills, is pioneering a groundbreaking, motion-sparing solution for this debilitating condition - one that no other surgeon in the world performs.
What is Bertolotti Syndrome?
Bertolotti Syndrome occurs when an abnormal, enlarged transverse process of the lower lumbar spine (usually L5) fuses partially or fully with the sacrum or pelvis. This can create asymmetric movement in the spine, leading to chronic pain, muscle spasms, and even nerve irritation - yet it's frequently misdiagnosed as typical disc issues or generalized lower back pain.
Patients often undergo years of unsuccessful treatments - including physical therapy, steroid injections, and even spinal fusions - without ever receiving the right diagnosis. Dr. Melamed is on a mission to change that.
Recognizing the Signs: Is It Bertolotti Syndrome?
Key symptoms of Bertolotti Syndrome include:
Chronic lower back pain - typically one-sided, though it can radiate across the lower back
Hip or buttock pain - often mistaken for hip joint issues
Pain that worsens with activity but improves with rest
Limited flexibility and discomfort while sitting or standing for prolonged periods
If you've been battling persistent back pain despite multiple treatments, and no one seems to have an answer, Bertolotti Syndrome could be the missing diagnosis.
The World's Only Motion-Sparing Solution
While many surgeons default to fusion - which limits mobility and can create long-term complications - Dr. Melamed has pioneered an entirely different unique approach. Using navigated endoscopic-assisted surgery, he offers a motion-sparing alternative that no other surgeon in the world performs.
This minimally invasive, highly advanced procedure involves using a small endoscope (a tiny camera) combined with computer navigation technology to precisely target and remove the abnormal bone overgrowth - without disturbing the healthy surrounding structures. The result? Patients experience dramatic pain relief while preserving the spine's natural movement.
Dr. Melamed's innovative method avoids the need for traditional open surgery, reduces scarring, speeds up recovery time, and most importantly - prevents fusion. This is a game changer for Bertolotti Syndrome patients, offering them a path to pain-free living without sacrificing flexibility and mobility.
Non-Narcotic Pain Management: A Healthier Approach to Healing
Chronic back pain sufferers are often handed a prescription for opioids, leading to a cycle of dependency that never truly addresses the root cause. Dr. Melamed is a strong advocate for non-narcotic pain management, offering his patients safer, more effective alternatives.
His approach includes:
Regenerative medicine to promote natural healing
Physical therapy to restore strength and mobility
Minimally invasive procedures to target pain at the source
"Pain relief shouldn't come at the cost of your health or independence. My goal is to get patients back to living their lives - fully mobile, pain-free, and without relying on addictive medications," says Dr. Melamed.
Why Choose Dr. Hooman Melamed?
Dr. Melamed's reputation speaks for itself - from saving patients who've been misdiagnosed for years to pioneering techniques that no other surgeon in the world offers, he's a true leader in the field of orthopedic spine surgery. With an unwavering commitment to innovation, compassion, and non-narcotic care, it's no wonder patients travel from all corners of the globe to seek his expertise.
If you've been living with unexplained chronic back pain - and suspect Bertolotti Syndrome could be the culprit - don't settle for incomplete answers or outdated treatments. Dr. Melamed's world-first motion-sparing solution could be the key to getting your life back.
To experience the future of spine surgery, call 424-21-SPINE or visit The Spine Pro's website or email the office of Dr. Melamed at: [email protected] and take the first step towards reclaiming your life.
Dr. Hooman Melamed is redefining the future of spine surgery - and for Bertolotti Syndrome patients, the future has never looked brighter.
About The Spine Pro:
The Spine Pro, founded in 2005 by Dr. Hooman M. Melamed, is a leading provider of cutting-edge, minimally invasive spinal treatments and scoliosis surgery in Los Angeles. With a focus on patient-centered care and a commitment to continuous innovation, The Spine Pro offers a comprehensive range of services, from non-surgical regenerative therapies to advanced surgical
interventions like artificial disc replacement and ultra minimally invasive spine surgery.
For more information, please visit thespinepro.com.
(424) 217-7463
SOURCE: The Spine Pro
View the original press release on ACCESS Newswire
S.F.Warren--AMWN